Mark Cherney
Board Member | Managing Director, The Cherney Group
Belmont Collaborative for Health Systems Innovation
Biography
A seasoned healthcare executive and investor, Mark has led IPOs, acquisitions, and growth strategies across sectors such as urology, cardiology, oncology, pharma distribution, and specialty pharma. He is Chairman & Co-Founder of Prologics Healthcare a management services company with a strong focus on revenue cycle management and operational management of various ancilliary services. He is also Managing Director of The Cherney Group and has advised leading private equity, venture capital firms and global consulting firms with due diligence.
Previously, he served as Executive Chairman & CEO of U.S. Urology Partners, CEO of Prologics, Inc. (precursor to Prologics Healthcare)and Founder & CEO of Dolphin Medical. His expertise in scaling and investing in healthcare companies expands over 5 decades.
Mark is a member of various Advisory Boards including Monticeto Medical a healthcare services company focused on the medical office building and tech enabled services market, Seed Healthcare a Venture Capital firm focused in the healthcare services sector and the Collaborative for Health System Innovation (CHSI) @ Belmont University and the Thomas F. Frist, Jr. College of Medicine.